Skip to main content
OpenTrials

Clinical trial condition

Glomerulosclerosis, Focal Segmental

Explore clinical trials studying Glomerulosclerosis, Focal Segmental. Study availability and eligibility vary by location and protocol.

80 public trials 30 recruiting studies
Refine in advanced search Browse all conditions

Glomerulosclerosis, Focal Segmental trial results

Active, Not Recruiting

Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis

NCT07219121

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Focal Segmental Glomerulosclerosis, +14 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Cornell Medical Center New York, United States
  • University of North Carolina Chapel Hill Morrisville, North Carolina, United States
  • Ohio State University Columbus, Ohio, United States
View Trial Details
Active, Not Recruiting

Atrasentan in Patients With Proteinuric Glomerular Diseases

NCT04573920

Conditions
Alport Syndrome, Autoimmune Diseases, Collagen Diseases, +26 more
Locations
  • Kidney Disease Medical Group Glendale, California, United States
  • Academic Medical Research Institute Los Angeles, California, United States
  • North America Research Institute San Dimas, California, United States
  • Stanford U School Of Medicine Stanford, California, United States
View all 33 locations
View Trial Details

Related conditions